STAT Plus: Cleveland Clinic’s Nissen denies any communication with FDA about Amarin’s Vascepa
Drama, thy name is Amarin. If you want to get a rise out of investors who have been following Amarin, the maker of the fish-oil-derived...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More